p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
复制标题
DOI:
10.1016/j.stemcr.2017.06.015
复制
发表时间:
2017-08-08
影响因子:
5.9
通讯作者:
Batista LFZ
中科院分区:
文献类型:
--
作者:
Fok WC;Niero ELO;Dege C;Brenner KA;Sturgeon CM;Batista LFZ
Dyskeratosis congenita (DC) is a bone marrow failure syndrome associated with telomere dysfunction. The progression and molecular determinants of hematopoietic failure in DC remain poorly understood. Here, we use the directed differentiation of human embryonic stem cells harboring clinically relevant mutations in telomerase to understand the consequences of DC-associated mutations on the primitive and definitive hematopoietic programs. Interestingly, telomere shortening does not broadly impair hematopoiesis, as primitive hematopoiesis is not impaired in DC cells. In contrast, while phenotypic definitive hemogenic endothelium is specified, the endothelial-to-hematopoietic transition is impaired in cells with shortened telomeres. This failure is caused by DNA damage accrual and is mediated by p53 stabilization. These observations indicate that detrimental effects of telomere shortening in the hematopoietic system are specific to the definitive hematopoietic lineages. This work illustrates how telomere dysfunction impairs hematopoietic development and creates a robust platform for therapeutic discovery for treatment of DC patients. CRISPR/Cas9 was used to generate different DC-associated mutations in hESCs Telomere shortening specifically impairs definitive hematopoietic specification Genetic instability and p53 activation regulate hematopoietic specification in DC In vitro hematopoietic failure resembles phenotypes of aplastic anemia in DC By directly assessing primitive or definitive hematopoiesis derived from telomerase-mutant hESCs, Batista and colleagues show that telomere shortening specifically impairs definitive hematopoietic potential, while primitive hematopoiesis is instead enhanced. This system offers the unprecedented capability to study hematopoietic failure and suggests that bone marrow failure in DC patients is reversible.
登录
查看更多内容
影响因子:
64.8
作者:
Batista, Luis F. Z.;Pech, MatthewF.;Zhong, Franklin L.;Nguyen, Ha Nam;Xie, Kathleen T.;Zaug, Arthur J.;Crary, Sharon M.;Choi, Jinkuk;Sebastiano, Vittorio;Cherry, Athena;Giri, Neelam;Wernig, Marius;Alter, Blanche P.;Cech, Thomas R.;Savage, Sharon A.;Pera, Renee A. Reijo;Artandi, Steven E.
通讯作者:
Artandi, Steven E.
影响因子:
46.9
作者:
Hockemeyer, Dirk;Soldner, Frank;Beard, Caroline;Gao, Qing;Mitalipova, Maisam;DeKelver, Russell C.;Katibah, George E.;Amora, Ranier;Boydston, Elizabeth A.;Zeitler, Bryan;Meng, Xiangdong;Miller, Jeffrey C.;Zhang, Lei;Rebar, Edward J.;Gregory, Philip D.;Urnov, Fyodor D.;Jaenisch, Rudolf
通讯作者:
Jaenisch, Rudolf
DOI:
10.1038/nrg3246
发表时间:
2012-10
期刊:
Nature reviews. Genetics
影响因子:
--
作者:
通讯作者:
--
影响因子:
21.3
作者:
Ditadi A;Sturgeon CM;Tober J;Awong G;Kennedy M;Yzaguirre AD;Azzola L;Ng ES;Stanley EG;French DL;Cheng X;Gadue P;Speck NA;Elefanty AG;Keller G
通讯作者:
Keller G
影响因子:
3.7
作者:
Gu,Bai-Wei;Apicella,Marisa;Mason,Philip J.
通讯作者:
Mason,Philip J.